Advanced search
Publication Cover
International Medical Case Reports Journal Volume 12, 2019 - Issue
Submit an article Journal homepage
88
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Transformation of ALK expression and PD-L1 0% to PD-L1 90% only after surgery: the need for rebiopsy in lung cancer patients

Christoforos Kosmidis1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Georgios Koimtzis1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Dimitrios Giannakidis1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Nikos Tteralli1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Stylianos Mantalovas1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Alexandros Tsakalidis1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Konstantina Tsopouridou1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Stefanos Atmatzidis1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
,
Lazaros Liavas1 3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece
&
Paul Zarogoulidis2 Department of Pharmacology and Clinical Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece, [email protected]Correspondence[email protected]
 show all
Pages 15-20 | Published online: 11 Jan 2019

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Paul Zarogoulidis, Dimitris Petridis, Haidong Huang, Chong Bai, Wolfgang Hohenforst-Schmidt, Lutz Freitag, Sofia Baka, Dimitris Drougas, Anastasios Vagionas, Kosmas Tsakiridis, J Francis Turner, Dimitris Hatzibougias, Ioannis Boukovinas, Bojan Zaric, Tomi Kovacevic, Aris Ioannidis, Nikolaos Courcoutsakis, Dimitris Matthaios & Chrisanthi Sardeli. (2021) Biopsy and re-biopsy for PD-L1 expression in NSCLC. association between PD-L1 and checkpoint inhibitor efficacy through treatment in NSCLC. A pilot study. Expert Review of Respiratory Medicine 15:11, pages 1483-1491.
Read now

Articles from other publishers (1)

Shun Iwai, Aika Funasaki, Atsushi Sekimura, Nozomu Motono, Katsuo Usuda, Sohsuke Yamada, Yoshimichi Ueda, Kyouta Akasaki, Kouta Tanimura, Kazumasa Kase & Hidetaka Uramoto. (2020) Emergence of lung cancer with a low PD-L1 expression level after the administration of immune check point inhibitor for lung adenocarcinoma with a high PD-L1 expression level: A case report. Annals of Medicine and Surgery 56, pages 82-85.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.